Clinical efficacy of osimertinib for a patient with ileus due to peritoneal carcinomatosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Clinical efficacy of osimertinib for a patient with ileus due to peritoneal carcinomatosis

Published:2020-01-03 Issue:2 Volume:8 Page:347-350
ISSN:2050-0904
Container-title:Clinical Case Reports
language:en
Short-container-title:Clin Case Rep

Author:

Kawaguchi Yo¹²^ORCID,Hanaoka Jun¹,Hayashi Hideki³⁴⁵⁶,Fukuda Yoshihisa⁴,Iihara Hirotoshi³⁶,Suzuki Akio⁶,Sugiyama Tadashi³⁴⁵

Affiliation:

1. Division of General Thoracic Surgery Department of Surgery Shiga University of Medical Science Otsu City Japan

2. Division of General Thoracic Surgery Kusatsu General Hospital Kusatsu City Japan

3. Laboratory of Pharmacy Practice and Social Science Gifu Pharmaceutical University Gifu City Japan

4. Laboratory of Community Healthcare Pharmacy Gifu Pharmaceutical University Gifu City Japan

5. Laboratory of Home Team Care Pharmacy Gifu Pharmaceutical University Gifu City Japan

6. Department of Pharmacy Gifu University Hospital Gifu City Japan

Publisher

Wiley

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ccr3.2645

Reference8 articles.

1. Peritoneal metastases from extra-abdominal cancer – A population-based study

2. Peritoneal carcinomatosis in lung cancer patients;Satoh H;Oncol Rep,2001

3. Peritoneal carcinomatosis in lung cancer

4. First-Line Gefitinib for Patients With Advanced Non–Small-Cell Lung Cancer Harboring Epidermal Growth Factor Receptor Mutations Without Indication for Chemotherapy

5. Simultaneous and rapid determination of gefitinib, erlotinib and afatinib plasma levels using liquid chromatography/tandem mass spectrometry in patients with non-small-cell lung cancer

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic Strategies and Oncological Outcome of Peritoneal Metastases from Lung Cancer: A Systematic Review and Pooled Analysis;Current Oncology;2023-03-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3